Deep Transcranial Magnetic Stimulation (dTMS) is a non-invasive brain stimulation technique approved by regulatory authorities, including the USFDA
Senvelgo is the first liquid once-daily, orally administered prescription medication to improve glycemic control in cats with diabetes mellitus
US FDA approval is in line with de-risking strategy for additional API site to service our global customer base
The inspection closed with zero observations and a classification of No Action Indicated
Erdafitinib is indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma
Shivalik Rasayan Limited has issued LOA to Medicamen Biotech to use its DMF grade Bortezomib API for formulation of Bortezomib injection 3.5mg/ vial
This product will be launched through Granules Consumer Health (GCH) division
USFDA concludes inspection at Zydus' formulation manufacturing facility at SEZ 2, Ahmedabad
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
This trial is a multi-national, phase 2/3, open-label, randomized, controlled clinical study of utidelone injectable
Subscribe To Our Newsletter & Stay Updated
